NOTE vs SONM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FiscalNote (NOTE) exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating fundamental instability. The company is experiencing a collapse in market value, with a 1-year price decline of 97.3% and shrinking revenue growth of -24.70%. Deeply negative profit margins (-68.39%) and high leverage (Debt/Equity of 2.44) suggest a high risk of insolvency or extreme dilution. Despite a stale analyst target price of $7.25, the deterministic data points to a company in a death spiral.
The company exhibits extreme financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental health. With a Quick Ratio of 0.03 and a negative Price-to-Book ratio of -4.35, the firm is facing a severe liquidity crisis and possesses negative shareholders' equity. Catastrophic Q/Q revenue growth of -394.48% and a 5-year price decline of 99.7% suggest a business in terminal decline. The lack of an Altman Z-Score calculation is likely due to the absence of positive working capital or equity, further signaling insolvency risk.
Compare Another Pair
Related Comparisons
NOTE vs SONM: Head-to-Head Comparison
This page compares FiscalNote Holdings, Inc. (NOTE) and DNA X, Inc. (SONM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.